HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Gaidano Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

11/2018Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials.
1/2018Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
1/2016Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Gaidano Research Topics

Disease

13Lymphoma (Lymphomas)
12/2016 - 02/2000
10Neoplasms (Cancer)
11/2018 - 05/2000
10B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018 - 05/2000
6Multiple Myeloma
01/2018 - 09/2000
6Acquired Immunodeficiency Syndrome (AIDS)
10/2000 - 01/2000
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2023 - 09/2002
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2018 - 01/2016
3Epstein-Barr Virus Infections
10/2000 - 05/2000
3Primary Effusion Lymphoma
04/2000 - 02/2000
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016 - 03/2015
2Leukemia
05/2014 - 09/2000
2Infections
03/2013 - 01/2001
2B-Cell Lymphoma (Lymphoma, B Cell)
07/2003 - 04/2000
2AIDS-Related Lymphoma (Lymphoma, AIDS Related)
08/2000 - 08/2000
1Second Primary Neoplasms (Neoplasms, Second)
11/2023
1Disease Progression
01/2018
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2018
1Trisomy (Trisomies)
01/2018
1Residual Neoplasm
12/2016
1Venous Thromboembolism
10/2016
1Hematologic Neoplasms (Hematological Malignancy)
01/2016
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2016
1Skin Neoplasms (Skin Cancer)
12/2014
1Thromboembolism
08/2014
1Thrombosis (Thrombus)
08/2014
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
08/2014
1Neutropenia
03/2013
1Anemia
03/2013
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2004
1Hemorrhage
01/2001
1Splenomegaly
01/2001
1Thrombocytopenia (Thrombopenia)
01/2001
1Virus Diseases (Viral Diseases)
10/2000
1Proteinuria
09/2000

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
12/2014 - 02/2000
5Rituximab (Mabthera)FDA Link
11/2023 - 01/2001
4DNA (Deoxyribonucleic Acid)IBA
12/2014 - 10/2000
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2018 - 01/2017
3carfilzomibIBA
01/2018 - 01/2017
3CytokinesIBA
01/2001 - 08/2000
3AntigensIBA
01/2001 - 05/2000
2Lenalidomide (CC 5013)FDA Link
11/2018 - 03/2013
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018 - 01/2016
2IntegrinsIBA
01/2018 - 10/2016
2Bortezomib (Velcade)FDA Link
01/2017 - 01/2017
2Transcription Factors (Transcription Factor)IBA
02/2015 - 05/2000
2Messenger RNA (mRNA)IBA
05/2014 - 01/2000
2Immunoglobulins (Immunoglobulin)IBA
12/2004 - 05/2000
2MethyltransferasesIBA
07/2003 - 07/2000
2Syndecan-1 (Syndecan 1)IBA
02/2001 - 04/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2001 - 01/2000
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2000 - 02/2000
2LigandsIBA
05/2000 - 02/2000
2EBV-encoded nuclear antigen 1IBA
05/2000 - 02/2000
1thiamine triphosphorate (TTP)IBA
11/2018
1NucleophosminIBA
11/2017
1carboxyl radical (COO-)IBA
12/2016
1Vitamin KFDA Link
10/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016
1Prednisolone (Predate)FDA LinkGeneric
01/2016
1Vincristine (Oncovin)FDA LinkGeneric
01/2016
1Azacitidine (5 Azacytidine)FDA Link
03/2015
1SteroidsIBA
08/2014
1Inosine Triphosphate (ITP)IBA
08/2014
1Thrombopoietin (c-mpl Ligand)IBA
08/2014
1Membrane Proteins (Integral Membrane Proteins)IBA
05/2014
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
04/2013
1Melphalan (Alkeran)FDA LinkGeneric
03/2013
1Chemokine ReceptorsIBA
08/2011
1ChemokinesIBA
08/2011
1NucleotidesIBA
03/2011
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
07/2003
1O-(6)-methylguanineIBA
07/2003
1RNA (Ribonucleic Acid)IBA
10/2000
1InterferonsIBA
10/2000
1Interferon Regulatory FactorsIBA
10/2000
1fludarabineIBA
09/2000
1Interleukin-12 (IL 12)IBA
08/2000
1Antisense OligonucleotidesIBA
08/2000
1Interleukin-7 (Interleukin 7)IBA
08/2000
1Interleukin-6 (Interleukin 6)IBA
08/2000
1Interleukin-10 (Interleukin 10)IBA
08/2000
1DNA Repair EnzymesIBA
07/2000
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
05/2000
1CyclinsIBA
04/2000
1Cyclin-Dependent Kinase Inhibitor p27IBA
04/2000
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
02/2000
1Codon (Codons)IBA
02/2000
1Prolactin Receptors (Prolactin Receptor)IBA
01/2000

Therapy/Procedure

3Therapeutics
11/2018 - 09/2000
3Drug Therapy (Chemotherapy)
01/2018 - 09/2002
2Radioimmunotherapy
11/2023 - 01/2016
2Stem Cell Transplantation
11/2023 - 09/2000
1Hematopoietic Stem Cell Transplantation
11/2023
1Duration of Therapy
10/2016
1Transplantation
04/2011
1Organ Transplantation
02/2004
1Orchiectomy (Orchidectomy)
09/2002
1Autologous Transplantation
09/2000
1Highly Active Antiretroviral Therapy (HAART)
08/2000